Product Information

RIZATRIPTAN 10 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.3280 per EA under NDC 33342008841. Its NADAC has been published 392 times since May 15, 2019.

FDA first approved this application on Feb 11, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RIZATRIPTAN 10 MG TABLET

Rizatriptan
$0.3280per EA

Strength

10 mg/1

NDC

33342008841

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

RIZATRIPTAN BENZOATE

Approval Type

Generic (ANDA)

FDA Application

ANDA203147

FDA Approved

2/11/2014

TE Code

AB

On Market Since

3/11/2014

Pharmacological Classes

Serotonin 1b Receptor Agonists
Serotonin 1d Receptor Agonists
Serotonin-1b and Serotonin-1d Receptor Agonist

Price Statistics

The NADAC for RIZATRIPTAN 10 MG TABLET has been published 392 times since May 15, 2019, and over the history we have for it it has declined 52.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3280 per EA
All-time high$0.8270 (Jun 12, 2019)
All-time low$0.3131 (May 22, 2024)
52-week high$0.4876
52-week low$0.3280
Median price$0.4823
Average price$0.5086
Largest weekly change+30.1% (Feb 22, 2023)
Weeks tracked392
Tracking sinceMay 15, 2019

Price History

1W

0.0%

1M

-2.2%

3M

-6.9%

6M

-23.9%

1Y

-33.3%

3Y

-3.6%

5Y

-51.4%

All

-52.4%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of RIZATRIPTAN 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for RIZATRIPTAN 10 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.3280 per EA (NDC 33342008841), effective Nov 11, 2026.

How has the price of RIZATRIPTAN 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for RIZATRIPTAN 10 MG TABLET has declined 52.4%. It has been tracked across 392 weekly CMS publications since May 15, 2019.

What are the highest and lowest recorded NADAC prices for RIZATRIPTAN 10 MG TABLET?

Since May 15, 2019, the NADAC for RIZATRIPTAN 10 MG TABLET has ranged from a low of $0.3131 (May 22, 2024) to a high of $0.8270 (Jun 12, 2019), with a median of $0.4823 per EA.

Are there cheaper alternatives to RIZATRIPTAN 10 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as RIZATRIPTAN 10 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures RIZATRIPTAN 10 MG TABLET?

RIZATRIPTAN 10 MG TABLET (NDC 33342008841) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.